LONG-TERM, SUSTAINED SAFETY AND EFFICACY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN MULTIPLE SCLEROSIS PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY

被引：0
|
作者：
Del Popolo, Giulio [1 ]
Panicker, Jalesh [2 ,3 ]
Aliotta, Philip [4 ]
Joshi, Manher [5 ]
Jenckins, Brenda [5 ]
Zheng, Yan [5 ]
Kohan, Alfred [6 ]
机构：
[1] Careggi Univ Hosp, Neurourol Dept, Florence, Italy
[2] Natl Hosp Neurol & Neurosurg, London, England
[3] UCL, Inst Neurol Queen Sq, London, England
[4] Western New York Urol Associates LLC, Cheektowaga, NY USA
[5] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[6] Adv Urol Ctr New York, Bethpage, NY USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
URINARY-INCONTINENCE;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
3
引用
收藏
页码：S3 / S4
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of OnabotulinumtoxinA in Treating Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis
    Zhou Xin
    Yan Hui-Lei
    Cui Yuan-Shan
    Zong Huan-Tao
    Zhang Yong
    中华医学杂志英文版, 2015, 128 (07) : 963 - 968
  • [42] Efficacy and Safety of OnabotulinumtoxinA in Treating Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis
    Zhou, Xin
    Yan, Hui-Lei
    Cui, Yuan-Shan
    Zong, Huan-Tao
    Zhang, Yong
    CHINESE MEDICAL JOURNAL, 2015, 128 (07) : 963 - 968
  • [43] Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review
    Akkoc, Yesim
    SPINAL CORD, 2022, 60 (10) : 854 - 861
  • [44] Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review
    Yesim Akkoc
    Spinal Cord, 2022, 60 : 854 - 861
  • [45] Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron
    Zachariou, Athanasios
    Filiponi, Maria
    Baltogiannis, Dimitrios
    Giannakis, John
    Dimitriadis, Fotios
    Tsounapi, Panagiota
    Takenaka, Atsushi
    Sofikitis, Nikolaos
    CANADIAN JOURNAL OF UROLOGY, 2017, 24 (06) : 9107 - 9113
  • [46] Long term follow-up of patients with multiple sclerosis and neurogenic detrusor overactivity treated with intravesical Botulinum Toxin
    Kealey, J.
    Yao, H.
    Chan, G.
    BJU INTERNATIONAL, 2021, 128 : 26 - 26
  • [47] Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Cheng, Tao
    Shuang, Wei-bing
    Jia, Dong-dong
    Zhang, Min
    Tong, Xu-nan
    Yang, Wei-dong
    Jia, Xu-ming
    Li, Shuo
    PLOS ONE, 2016, 11 (07):
  • [48] Low but sustained detrusor contractility, detrusor retrospective analysis of treatment outcomes and overactivity and bladder outlet obstruction in female medical care of patients with neurogenic detrusor patients with multiple sclerosis
    Tubaro, A.
    Arrighi, M.
    De Nunzio, C.
    Trucchi, A.
    Miano, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 212 - 212
  • [49] Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
    Tuohy, Orla
    Costelloe, Lisa
    Hill-Cawthorne, Grant
    Bjornson, Ingunn
    Harding, Katharine
    Robertson, Neil
    May, Karen
    Button, Tom
    Azzopardi, Laura
    Kousin-Ezewu, Onajite
    Fahey, Michael T.
    Jones, Joanne
    Compston, D. Alastair S.
    Coles, Alasdair
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 208 - 215
  • [50] EFFICACY AND SAFETY OF THREE ACTIVE DOSES OF ONABOTULINUMTOXINA FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY IN CHILDREN: RESULTS OF A RANDOMIZED CONTROLLED CLINICAL TRIAL
    Austin, Paul F.
    Franco, Israel
    Dobremez, Eric
    Kroll, Pawel
    Titanji, Wilson
    Geib, Till
    Jenkins, Brenda
    Hoebeke, Piet B.
    TOXICON, 2021, 190 : S6 - S6
12345